Floatz logo

Cytosin-Arabinosid

Childhood Myelodysplastic Syndrome

Children's Oncology GroupPhase 3Active
BBB
72/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
63/ 100
Competitive Position
89/ 100

Competitive context

5 Active assets in the Childhood Myelodysplastic Syndrome cohort.

Asset / SponsorPhaseRating
Fludarabine
Children's Oncology Group
Phase 3BBB
CYCLOSPORIN A
Fred Hutchinson Cancer Center
Phase 3BB
ETOPOSIDE
City of Hope Medical Center
Phase 3BB
Busulphan
Fred Hutchinson Cancer Center
Phase 3BB
METHOTREXATE
Children's Oncology Group
Phase 3BB

View all 33 →

Same molecule, other indications

Cytosin-Arabinosid is also rated in:

acute promyelocytic leukemiaDormant
A
Indicative ·
82 / 100
View asset →
adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →